Hemogenyx Pharmaceuticals PLC logo

Hemogenyx Pharmaceuticals PLC

NEW
LSE:HEMO (UK)  
£ 6.55 +0.13 (+1.95%) Aug 11
At Loss
P/B:
33.08
Market Cap:
£ 44.54M ($ 60.10M)
Enterprise V:
£ 44.91M ($ 60.59M)
Volume:
11.60K
Avg Vol (2M):
11.99K
Trade In:
Volume:
11.60K
At Loss
Avg Vol (2M):
11.99K

Hemogenyx Pharmaceuticals PLC (LSE:HEMO) Dividend

Hemogenyx Pharmaceuticals PLC (LSE:HEMO) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -35.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LSE:HEMO Dividend

Does Hemogenyx Pharmaceuticals PLC (LSE:HEMO) pay a dividend?

Hemogenyx Pharmaceuticals PLC (LSE:HEMO) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Hemogenyx Pharmaceuticals PLC pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Hemogenyx Pharmaceuticals PLC has returned capital to shareholders via buybacks at a rate of -35.1% over the past 3 years.

What are dividend-paying alternatives to Hemogenyx Pharmaceuticals PLC?

For dividend-paying alternatives in Hemogenyx Pharmaceuticals PLC's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.